title: Dendritic cell and effector cell infiltration in soft tissue sarcomas with reactive lymphoid hyperplasia.
abstract: The lymph node is the site of antigen presentation, and dendritic cells are sentinels for anti-tumor immunity. However, little is known about the histological features of lymph nodes and dendritic cells in soft tissue sarcomas. The reactive lymph node and infiltration of dendritic cells or effector cells were studied histologically in 10 soft tissue sarcomas with reactive lymphoid hyperplasia. The cases included four malignant fibrous histiocytomas, two malignant peripheral nerve sheath tumors, one synovial sarcoma, one epithelioid sarcoma, one malignant granular cell tumor, and one liposarcoma. The proportions of the T zone, lymphoid follicle, and lymphoid sinus (which was occupied by cells immunopositive for antibodies against CD3, CD20, or CD68) were 33.4% +/- 11.0%, 6.1% +/- 4.9%, and 13.5% +/- 6.5%, respectively. T zone hyperplasia was observed in all cases, and sinus histiocytosis was found in four. The proportion of the T zone in regional lymph nodes of soft tissue sarcoma patients was significantly higher than that in adult autopsy cases without a cancer history. CD8-, TIA-1-, or granzyme B-positive effector cells were found in each sarcoma tissue. Whereas CD1a-positive dendritic cells were not detected, S-100 protein-positive or CD83-positive dendritic cells were observed in five sarcoma tissues. The coefficient correlation between the numbers of effector cells and dendritic cells positive for CD83 or S-100 protein were demonstrated. Although this is a preliminary report, the present study demonstrated that some soft tissue sarcoma patients showed reactive lymphoid hyperplasia. Furthermore, the association between the infiltration of dendritic cells and that of effector cells was observed in patients with soft tissue sarcomas.
authors.affiliation: Department of Orthopaedic Surgery, Yamagata University School of Medicine, Iida-nishi, Yamagata 990-9585, Japan.
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Orui
authors.forename: Akira
authors.initials: A
authors.lastname: Ishikawa
authors.forename: Kyoji
authors.initials: K
authors.lastname: Okada
authors.forename: Jun
authors.initials: J
authors.lastname: Nishida
authors.forename: Hiroko
authors.initials: H
authors.lastname: Mitsui
authors.forename: Hideo
authors.initials: H
authors.lastname: Kashiwa
authors.forename: Takashi
authors.initials: T
authors.lastname: Tsuchiya
authors.forename: Toshihiko
authors.initials: T
authors.lastname: Ogino
authors.forename: Mitsunori
authors.initials: M
authors.lastname: Yamakawa
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D015703:Antigens, CD; D016827:CD8 Antigens / Q000378:metabolism; D003713:Dendritic Cells; D005260:Female; D006801:Humans; D007136:Immunoglobulins / Q000378:metabolism; D007150:Immunohistochemistry; D008297:Male; D008562:Membrane Glycoproteins / Q000378:metabolism; D008875:Middle Aged; D019310:Pseudolymphoma / Q000150:complications / Q000473:pathology*; D012509:Sarcoma / Q000150:complications / Q000473:pathology*; D012983:Soft Tissue Neoplasms / Q000150:complications / Q000473:pathology*; D000097802:CD83 Antigen
chemical_list: D015703:Antigens, CD; D016827:CD8 Antigens; D007136:Immunoglobulins; D008562:Membrane Glycoproteins; D000097802:CD83 Antigen